Publicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (8)

2024

  1. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

2023

  1. iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy

    Circulation Research, Vol. 133, Núm. 2, pp. 108-119

2022

  1. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  2. Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

    ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078

2021

  1. Importance of blood pressure control and adequate neurohormonal treatment in LVAD patients: Comment to paper by Tran T. et al.

    Journal of Heart and Lung Transplantation

  2. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

2016

  1. Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation

    Europace, Vol. 18, Núm. 6, pp. 873-880

2015

  1. Long-Term Outcome After Ablation of Right Atrial Tachyarrhythmias After the Surgical Repair of Congenital and Acquired Heart Disease

    American Journal of Cardiology, Vol. 115, Núm. 12, pp. 1705-1713